These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3814669)

  • 21. Phenylethylamine and schizophrenia.
    O'Reilly RL; Davis BA
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):63-75. PubMed ID: 7906896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of thought disorder in paranoid and non-paranoid schizophrenia.
    Mazumdar PK; Chaturvedi SK; Gopinath PS
    Psychopathology; 1991; 24(3):166-9. PubMed ID: 1754647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased cerebrospinal fluid levels of beta-phenylethylamine in patients with Rett syndrome.
    Satoi M; Matsuishi T; Yamada S; Yamashita Y; Ohtaki E; Mori K; Riikonen R; Kato H; Percy AK
    Ann Neurol; 2000 Jun; 47(6):801-3. PubMed ID: 10852546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
    Sabelli HC; Javaid JI
    J Neuropsychiatry Clin Neurosci; 1995; 7(1):6-14. PubMed ID: 7711493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The P 300 potential in schizophrenia].
    Laurent A; Garcia-Larrea L; Dalery J; Terra JL; D'Amato T; Marie-Cardine M; Mauguière F
    Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are paranoid schizophrenics biologically different from other schizophrenics?
    Potkin SG; Cannon HE; Murphy DL; Wyatt RJ
    N Engl J Med; 1978 Jan; 298(2):61-6. PubMed ID: 619236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet monoamine oxidase B and plasma beta-phenylethylamine in Parkinson's disease.
    Zhou G; Miura Y; Shoji H; Yamada S; Matsuishi T
    J Neurol Neurosurg Psychiatry; 2001 Feb; 70(2):229-31. PubMed ID: 11160474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients.
    Singh B; Bera NK; Nayak CR; Chaudhuri TK
    Cytokine; 2009 Jul; 47(1):1-5. PubMed ID: 19502081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretion pattern of endogenous opioids in chronic schizophrenia.
    Brambilla F; Facchinetti F; Petraglia F; Vanzulli L; Genazzani AR
    Am J Psychiatry; 1984 Oct; 141(10):1183-9. PubMed ID: 6091463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenylethylamine excretion in depression.
    DeLisi LE; Murphy DL; Karoum F; Mueller E; Targum S; Wyatt RJ
    Psychiatry Res; 1984 Nov; 13(3):193-201. PubMed ID: 6597458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The mRNA expression levels of IL-1beta, TNF-alpha and tyrosine hydroxylase in peripheral blood of paranoid schizophrenic patients].
    Liu L; Jia FJ; Li HF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1043-5. PubMed ID: 17988588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of endocannabinoids in postmortem brain of schizophrenic subjects.
    Muguruza C; Lehtonen M; Aaltonen N; Morentin B; Meana JJ; Callado LF
    Schizophr Res; 2013 Aug; 148(1-3):145-50. PubMed ID: 23800614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free and conjugated plasma homovanillic acid in schizophrenic patients.
    Garcia A; Galinowski A; Guicheney P; Mignot E; Loo H; Meyer P
    Biol Psychiatry; 1989 May; 26(1):87-96. PubMed ID: 2720023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The measurement of beta-phenylethylamine in human plasma and rat brain.
    Huebert ND; Schuurmans Schwach V; Richter G; Zreika M; Hinze C; Haegele KD
    Anal Biochem; 1994 Aug; 221(1):42-7. PubMed ID: 7985801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatidylserine inhibition of monoamine oxidase in platelets of schizophrenics.
    Tachiki KH; Buckman TD; Eiduson S; Kling AS; Hullett J
    Biol Psychiatry; 1986 Jan; 21(1):59-68. PubMed ID: 3942801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenylethylamine metabolism in Tourette's syndrome.
    Bornstein RA; Baker GB; Carroll A; King G; Ashton S
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):408-12. PubMed ID: 2136393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine differences among subtypes of schizophrenic disorder? An investigation with the dexamethasone suppression test.
    Banki CM; Arató M; Rihmer Z
    Neuropsychobiology; 1984; 11(3):174-7. PubMed ID: 6472604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum testosterone differences between patients with schizophrenia and those with affective disorder.
    Mason JW; Giller EL; Kosten TR
    Biol Psychiatry; 1988 Feb; 23(4):357-66. PubMed ID: 3342266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Projection of an endocoid involved with schizophrenic reaction.
    Proctor CD; Cho JB; Nicolls AA
    Prog Clin Biol Res; 1985; 192():387-93. PubMed ID: 4080716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine.
    Baker GB; Coutts RT; Rao TS
    Br J Pharmacol; 1987 Oct; 92(2):243-55. PubMed ID: 2890391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.